Your browser doesn't support javascript.
loading
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
Chandasana, Hardik; Thapar, Mita; Hayes, Siobhan; Baker, Mark; Gibb, Diana M; Turkova, Anna; Ford, Deborah; Ruel, Theodore; Wiznia, Andrew; Fairlie, Lee; Bwakura-Dangarembizi, Mutsa; Mujuru, Hilda; Alvero, Carmelita; Farhad, Mona; Hazra, Rohan; Townley, Ellen; Buchanan, Ann; Bollen, Pauline; Waalewijn, Hylke; Colbers, Angela; Burger, David; Acosta, Edward P; Singh, Rajendra.
Afiliação
  • Chandasana H; Clinical Pharmacology, Modeling and Simulation, GSK, 1250 South Collegeville Road, Collegeville, PA, 19406, USA. hardik.x.chandasana@gsk.com.
  • Thapar M; ICON, Reading, UK.
  • Hayes S; ICON, Reading, UK.
  • Baker M; ViiV Healthcare, Nyon, Switzerland.
  • Gibb DM; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Turkova A; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Ford D; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Ruel T; University of California, San Francisco, San Francisco, CA, USA.
  • Wiznia A; Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Fairlie L; Faculty of Health Sciences, Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.
  • Bwakura-Dangarembizi M; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Mujuru H; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Alvero C; Frontier Science Foundation, Brookline, MA, USA.
  • Farhad M; Frontier Science Foundation, Brookline, MA, USA.
  • Hazra R; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Townley E; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Buchanan A; ViiV Healthcare, Durham, NC, USA.
  • Bollen P; Department of Pharmacy, Radboudumc Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Waalewijn H; Department of Pharmacy, Radboudumc Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Colbers A; Department of Pharmacy, Radboudumc Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Burger D; Department of Pharmacy, Radboudumc Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Acosta EP; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Singh R; Clinical Pharmacology, Modeling and Simulation, GSK, 1250 South Collegeville Road, Collegeville, PA, 19406, USA.
Clin Pharmacokinet ; 62(10): 1445-1459, 2023 10.
Article em En | MEDLINE | ID: mdl-37603217
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article